Gilead Sciences Inc (NASDAQ:GILD)

59.50
Delayed Data
As of Nov 25
 -0.75 / -1.24%
Today’s Change
57.04
Today|||52-Week Range
85.97
-8.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line18.1B13.5B4.6B5.5B
 
 
 
 
 
Depreciation1.1B1.2B1.3B1.4B
 
 
 
 
 
Total Other Cash Flow355.0M780.0M942.0M2.2B
 
 
 
 
 
Funds From Operations19.2B15.3B6.8B9.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-1.2B-1.4B-5.1B939.0M
 
 
 
 
 
Net Cash Flow - Operating Activities20.3B16.7B11.9B8.4B
 
 
 
 
 
 
InvestingIncrease In Investments-17.2B-26.0B-23.3B-10.6B
 
 
 
 
 
Decrease In Investments5.5B14.7B18.3B25.9B
 
 
 
 
 
Capital Expenditures-747.0M-748.0M-590.0M-924.0M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-10.4B0.00
 
 
Net Cash Flow Investing-12.5B-12.0B-16.1B14.4B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings10.7B6.2B9.0B0.00
 
 
 
 
Long Term Debt Reduction-997.0M-2.0B-1.8B-6.3B
 
 
 
 
 
Net Proceeds Stock Sale319.0M208.0M234.0M289.0M
 
 
 
 
 
Common Preferred Redeemed-10.0B-11.0B-954.0M-2.9B
 
 
 
 
 
Common Dividends-1.9B-2.5B-2.7B-3.0B
 
 
 
 
 
Cash Dividends Paid - Total-1.9B-2.5B-2.7B-3.0B
 
 
 
 
 
Other Sources - Financing773.0M194.0M0.000.00
 
 
 
Other Uses - Financing3.9B561.0M330.0M486.0M
 
 
 
 
 
Net Cash Flow - Financing-5.0B-9.3B3.4B-12.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-67.0M41.0M137.0M-85.0M
 
 
 
 
 
 
Net Change In Cash2.9B-4.7B-778.0M10.4B